The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment

By Duffy S.   Jackson T.L.   Lansdown M.   Philips K.   Wells M.   Pollard S.   Clack G.   Coibion M.   on behalf of the ATAC Trialists’ Group  

Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. : 545-553

Oxford University Press

Access to resources Recommend Favorite

The Value of Transvaginal Ultrasonography in the Endometrial Evaluation of Breast Cancer Patients Using Tamoxifen

By  

Medical Principles and Practice, Vol. 19, Iss. 3, 2010-03 ,pp. : 222-227

Karger

Access to resources Recommend Favorite

The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia.

By Vercellini P   Cortesi I   Oldani S   Moschetta M   De Giorgi O   Crosignani P G  

Human Reproduction, Vol. 12, Iss. 8, 1997-08 ,pp. : 1768-1771

Oxford University Press

Access to resources Recommend Favorite

Texture analysis of perimenopausal and post-menopausal endometrial tissue in grayscale transvaginal ultrasonography

By Michail G   Karahaliou A   Skiadopoulos S   Kalogeropoulou C   Terzis G   Boniatis I   Costaridou L   Kourounis G   Panayiotakis G  

British Journal of Radiology, Vol. 80, Iss. 956, 2007-08 ,pp. : 609-616

British Institute of Radiology

Access to resources Recommend Favorite

Prevalence of Endometrial Proliferation in Pipelle Biopsies in Tamoxifen-Treated Postmenopausal Women with Breast Cancer in Kuwait

By  

Medical Principles and Practice, Vol. 13, Iss. 1, 2003-12 ,pp. : 30-34

Karger

Access to resources Recommend Favorite